JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2015. Vol. 60. No. 1. P. 33-38
RADIATION THERAPY
O.P. Trofimova, O.I. Cheban, Z.P. Mikhina, S.V. Medvedev, Ju.I. Prjamikova, N.P. Schipilina, E.V. Timoshkina, E.V. Poddubskaya, A.A. Maklakova, N.V. Vekova, O.C. Zaichenko, A.V. Berdnik, Ju.V. Bikova, M.P. Baranova, I.P. Kovalenko, L.E. Rotobelskaya, S.I. Tkachev
Cardiovascular Complications in Patients with Breast Cancer After Breast-Conserving Treatment
N.N.Blokhin Russian Cancer research center, Moscow, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To evaluate the radiation dose on the heart in patients with left-sided localization of breast cancer receiving radiation therapy after breast-concerving treatment on the free breath and breath-hold at a deep breath.
Material and methods: The study included 113 patients with verified breast cancer T1-2N0-1M0 st. with left-sided localization of tumors who were treated in the N.N. Blokhin Russian Cancer Research Center in 2012-2013. Patients were treated with radical organ resection followed by radiation therapy. Radiation therapy (RT) on the free breath was carried out in 53 patients and on breath-hold at deep breaths in 60 patients. RT - 5 times per week dose 2 Gy per day to a total dose of 50 Gy. Radiation dose distribution in under risk organs was assessed for clinical radiotherapy planning parameters V25 Gy and Dmean to heart.
Results: The data presented show a significant reduction in the volume of the heart, which received a dose of 25 Gy - median performance V25 in RT sync breathing in comparison with the free breathing below the 82 % and the average dose of heart-median performance below the 65 %. The difference is not reliable because of the small number of observations.
Conclusion: The RT with breath holding on deep inhalation in patients with left-sided breast cancer localization reduces an average dose to the heart and the heart volume at the dose of 25 Gy. This allows to expect a further reduction in the incidence of cardio-vascular complications.
Key words: radiotherapy, breast cancer, cardiovascular complications
REFERENCES
- Kaprin A.D., Starinskii V.V., Petrova G.V. Zlokachestvennye novoobrazovaniya v Rossii v 2012 g. (zabolevaemost' i smertnost'). Moscow: FGBU «MNIOI im. P.A. Gertsena» Minzdrava Rossii. 2014. P. 10-12.
- Gagliardi G., Constine L., Moiseeko V. Radiation dose-volume effects in the heart. Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 76. No. 3. P. S77-S85.
- Carver J.R., Shapiro Ch.L., Jacobs A. et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J. Clin. Oncol. 2007. Vol. 1. No. 25. P. 3991-4008.
- Clarke M., Collins R., Darby S. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trials. Lancet, 2005. Vol. 366. No. 9503. P. 2087-2106.
- Ridker P.M., Buring J.E., Rifai N. et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds score. J. Amer. Med. Assoc. 2007. Vol. 297. No. 6. P. 611-619.
- Hooning M.J., Botma A., Aleman B.M. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J. Natl. Cancer Inst. 2007. Vol. 99. No. 5. P. 365-375.
- Paszat L.F., Mackillop W.J., Groome P.A. Mortality from myocardial infarction following postmastectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int. J. Radiat. Oncol. Biol. Phys. 1999. Vol. 43. No. 2. P. 755-761.
- Harris E.E., Correa C., Hwang W.T. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J. Clin. Oncol. 2006. Vol. 24. No. 25. P. 4100-4106.
- Lipshultz S.E., Lipsitz S.R., Sallan S.E. et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J. Clin. Oncol. 2002. Vol. 20. No. 23. P. 4517-4522.
- Swain S.M., Whaley F.S., Ewer M.S. et al. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer. 2003. Vol. 97. No. 11. P. 2869-2879.
- Shapiro C.L., Hardenbergh P.H., Gelman R. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J. Clin. Oncol. 1998. Vol. 16. No. 11. P. 3493-3501.
- Adams M.J., Hardenbergh P.H., Constine L.S. et al. Radiation-associated cardiovascular disease. Crit. Rev. Oncol. Hematol. 2003. Vol. 45. No. 1. P. 55-75.
- Prosnitz R.G., Chen Y.H., Marks L.B. Cardiac toxicity following thoracic radiation. Semin. Oncol. 2005. Vol. 32. No. 2. P. S71-S80.
- Wei X., Liu H.H., Tucker S.L. et al. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2008. Vol. 70. No. 3. P. 707-714.
- Cuzick J., Stewart H., Rutqvist L. et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J. Clin. Oncol. 1994. Vol. 12. No. 3. P. 447-453.
- Marks L.B., Yu X., Prosnitz R.G. et al. The incidence functional consequences of RT-associated cardiac perfusion defects. Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 63. No. 1. P. 214-223.
- Darby S.C., McGale P., Taylor C.W. et al. Long-term mortality from heart disease study of about 300 000 women in US SEER cancer registries. Lancet Oncol. 2005. Vol. 6. No. 8. P. 557-565.
- Patt D.A., Goodwin J.S., Kuo Y.F. et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J. Clin. Oncol. 2005. Vol. 23. No. 30. P. 7475-7482.
- Borger J.N., Hooning M.J., Boersma L.J. et al. Cardiotoxic effects of tangential breast irradiation in early breast patients: The role of irradiated heart volume. Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 69. No. 4. P. 1131-1138.
- Utehina O. Healthy tissue sparing postoperative radiotherapy for treatment of early stage breast cancer. Riga. Summary of the doctoral thesis. 2009. 32 p.
For citation: Trofimova OP, Cheban OI, Mikhina ZP, Medvedev SV, Prjamikova JuI, Schipilina NP, Timoshkina EV, Poddubskaya EV, Maklakova AA, Vekova NV, Zaichenko OC, Berdnik AV, Bikova JuV, Baranova MP, Kovalenko IP, Rotobelskaya LE, Tkachev SI. Cardiovascular Complications in Patients with Breast Cancer after Breast-Conserving Treatment. Medical Radiology and Radiation Safety. 2015;60(1):33-8. Russian.
PDF (RUS) Full-text article (in Russian)